Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $191.55M.
ENTERPRISE VALUE (EV)
$191.55M
Neuronetics, Inc.
Market Cap
$154.32M
Enterprise Value (EV)
$191.55M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Neuronetics, Inc. (STIM) | $154.32M | $191.55M |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A |
| Inogen, Inc. (INGN)vs › | $156.68M | $85.20M |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | $132.71M |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $158.14M | $175.51M |
| PepGen Inc. (PEPG)vs › | $158.74M | $152.07M |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | $140.10M |
| Coherus Oncology, Inc. (CHRS)vs › | $159.91M | $114.69M |
| ALX Oncology Holdings Inc. (ALXO)vs › | $148.69M | $135.71M |
| Minerva Neurosciences, Inc. (NERV)vs › | $161.43M | $136.78M |
Market Cap
$154.32M
Total Debt
$71.37M
Cash
$34.13M
Enterprise Value
$191.55M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
